Ifinatamab Deruxtecan in Patients With Extensive-Stage Small Cell Lung Cancer: Primary Analysis of the Phase II IDeate-Lung01 Trial
- DOI
- 10.1200/jco-25-02142
- Published
- 2026-02
- Container
- Journal of Clinical Oncology
- Publisher
- American Society of Clinical Oncology (ASCO)
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1200/jco-25-02142,
title = {Ifinatamab Deruxtecan in Patients With Extensive-Stage Small Cell Lung Cancer: Primary Analysis of the Phase II IDeate-Lung01 Trial},
author = {Charles M. Rudin and Melissa L. Johnson and Luis Paz-Ares and Makoto Nishio and Christine L. Hann and Nicolas Girard and Pedro Rocha and Hidetoshi Hayashi and Tetsuya Sakai and Yu Jung Kim and Haichuan Hu and Meng Qian and Jasmeet Singh and Juliette Godard and Mei Tang and Myung-Ju Ahn},
year = {2026},
journal = {Journal of Clinical Oncology},
doi = {10.1200/jco-25-02142},
url = {https://doi.org/10.1200/jco-25-02142}
}RIS
TY - JOUR TI - Ifinatamab Deruxtecan in Patients With Extensive-Stage Small Cell Lung Cancer: Primary Analysis of the Phase II IDeate-Lung01 Trial AU - Charles M. Rudin AU - Melissa L. Johnson AU - Luis Paz-Ares AU - Makoto Nishio AU - Christine L. Hann AU - Nicolas Girard AU - Pedro Rocha AU - Hidetoshi Hayashi AU - Tetsuya Sakai AU - Yu Jung Kim AU - Haichuan Hu AU - Meng Qian AU - Jasmeet Singh AU - Juliette Godard AU - Mei Tang AU - Myung-Ju Ahn PY - 2026 JO - Journal of Clinical Oncology DO - 10.1200/jco-25-02142 UR - https://doi.org/10.1200/jco-25-02142 ER -
APA
Rudin, C. M., Johnson, M. L., Paz-Ares, L., Nishio, M., Hann, C. L., Girard, N., Rocha, P., Hayashi, H., Sakai, T., Kim, Y. J., Hu, H., Qian, M., Singh, J., Godard, J., Tang, M., & Ahn, M. (2026). Ifinatamab Deruxtecan in Patients With Extensive-Stage Small Cell Lung Cancer: Primary Analysis of the Phase II IDeate-Lung01 Trial. Journal of Clinical Oncology. https://doi.org/10.1200/jco-25-02142
Source records
- crossref · retrieved 2026-09-27T15:57:23.049Z